Virtual Non-Compliance with Omega-3 Treatment Results in Null Effects: The RANGER study
William S. Harris Prostaglandins, Leukotrienes and Essential Fatty Acids Articles in Press E-mail Alert - July 7, 2021
Highlights
• ISSFAL recommends that omega-3 blood levels be reported in treatment studies.
• A recent study found no effect of omega-3 on cognitive function in soldiers.
• Blood tests showed that the lack of effect was due to significant non-compliance.
• Studies that don't give a treatment should not expect to find an effect.
A recent paper reported that 14 weeks of treatment with 2100 mg of EPA+DHA from krill oil had no effect on cognitive function in US Army Ranger trainees. Although the authors stated that poor compliance “may have contributed to a failure to detect a response,” no indication of exactly how poor the compliance was is given. We have therefore calculated, based on their reported blood EPA+DHA levels and published equations predicting how a given dose of EPA+DHA should affect erythrocyte EPA+DHA levels (i.e., the Omega-3 Index), that the effective compliance was actually <3%. This study underscores the importance of adhering to ISSFAL recommendations that baseline and end of study blood omega-3 levels always be reported in intervention studies.
In this case the observed changes in blood levels are critical for interpreting the findings: there was no effect because there was essentially no intervention.